Published in
Elsevier, Journal of Investigative Dermatology, 7(141), p. 1847-1851, 2021
DOI: 10.1016/j.jid.2020.11.031
Links
Tools
A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis
Journal article published in 2021 by
Stephen C. Piscitelli 
,
Ana B. Pavel ,
Kimberly McHale ,
John E. Jett ,
Jon Collins ,
Dawn Gillmor ,
Glenn Tabolt ,
Randall Li ,
Teresa Song ,
Ning Zhang ,
Anna M. Tallman ,
Emma Guttman-Yassky
,
Ana B. Pavel ,
Kimberly McHale ,
John E. Jett ,
Jon Collins ,
Dawn Gillmor ,
Glenn Tabolt ,
Randall Li ,
Teresa Song ,
Ning Zhang ,
Anna M. Tallman ,
Emma Guttman-Yassky
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 